• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Division of Non-Prescription Drugs and Health Fraud

Director: Elizabeth Miller, Pharm.D.

Branch Chief, Over-the-Counter Drugs Branch: Anuj Shah, J.D.

Branch Chief, Health Fraud and Consumer Outreach Branch: Brad Pace, J.D. 

Project Management Officer: Sudha Shukla, Pharm.D.  


The Division of Non-Prescription Drugs and Health Fraud (DNPDHF) directs field inspections and investigations and recommends, directs and/or coordinates case development and compliance actions related to both fraudulent drug products and OTC drug products.  In addition, DNPDF provides enforcement and litigation support and guidance relating to these products.   

DNPDHF uses risk-based assessments to identify and prioritize fraudulent and OTC drug products for regulatory action and develops compliance strategies to address violations.  DNPDHF also reviews and develops legislative proposals and implements regulations, policy documents, enforcement strategies, and outreach activities related to these drug products.
 

For additional information, please visit: